Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-04-19 to 2022-05-10
Current total value of award: $5755.5
Description: 4556964940!ZOLADEX 3.6 MG IMPLANT SYRNS